Table: Brightpath Biotherapeutics -Q1 group results

BrightPath Biotherapeutics Co

10/08/2018 07:00

Aug 10 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2018        Jun 30, 2017      Mar 31, 2019  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            122 mln             90 mln            150 mln    
                 (+34.7 pct)                           (-57.7 pct)  
  Operating     loss 397 mln        loss 262 mln        loss 2.20   
  Recurring     loss 399 mln        loss 262 mln        loss 2.20   
  Net           loss 583 mln        loss 263 mln        loss 2.20   
  EPS          loss 13.94 yen       loss 7.08 yen    loss 52.59 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T